Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schwabl

Showing results (251-260 of 318) with videos related to

Pageof 32
Sort By:
United European Gastroenterology Journal|March 28, 2020
Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosisGeorg Semmler, Katharina Wöran, Bernhard Scheiner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2014
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3Mattias Mandorfer, Berit A Payer, Philipp Schwabl, et al.
United European Gastroenterology Journal|December 21, 2024
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, et al.
Molecular Biology and Evolution|March 13, 2023
Testosterone Coordinates Gene Expression Across Different Tissues to Produce Carotenoid-Based Red OrnamentationSarah Khalil, Erik D Enbody, Carolina Frankl-Vilches, et al.
Journal of Hepatology|June 1, 2016
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertensionMattias Mandorfer, Karin Kozbial, Philipp Schwabl, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 25, 2019
The Tcf21 lineage constitutes the lung lipofibroblast populationJuwon Park, Malina J Ivey, Yanik Deana, et al.
European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2020
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionBernhard Scheiner, Albert F Stättermayer, Philipp Schwabl, et al.
Pageof 32

Showing results (251-260 of 318) with videos related to

Sort By:
Pageof 32
United European Gastroenterology Journal|March 28, 2020
Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosisGeorg Semmler, Katharina Wöran, Bernhard Scheiner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2014
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3Mattias Mandorfer, Berit A Payer, Philipp Schwabl, et al.
United European Gastroenterology Journal|December 21, 2024
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, et al.
Molecular Biology and Evolution|March 13, 2023
Testosterone Coordinates Gene Expression Across Different Tissues to Produce Carotenoid-Based Red OrnamentationSarah Khalil, Erik D Enbody, Carolina Frankl-Vilches, et al.
Journal of Hepatology|June 1, 2016
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertensionMattias Mandorfer, Karin Kozbial, Philipp Schwabl, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 25, 2019
The Tcf21 lineage constitutes the lung lipofibroblast populationJuwon Park, Malina J Ivey, Yanik Deana, et al.
European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2020
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionBernhard Scheiner, Albert F Stättermayer, Philipp Schwabl, et al.
Pageof 32